| 2023年年报 | 2022年年报 | |
|---|---|---|
| 营业收入(元) | ||
| CDMO(元) | 200,518,499.42 | 504,136,977.78 |
| 贸易类(元) | 40,184,207.92 | 31,981,448.50 |
| 原料药及中间体(元) | 747,070,235.29 | 680,905,207.27 |
| 制剂类(元) | 220,934,775.24 | 222,588,325.69 |
| 营业成本(元) | ||
| CDMO(元) | 147,661,400.27 | 242,140,872.80 |
| 贸易类(元) | 34,934,570.16 | 26,801,016.30 |
| 原料药及中间体(元) | 525,300,176.87 | 480,909,053.45 |
| 制剂类(元) | 125,942,709.84 | 109,559,580.71 |
| 毛利(元) | ||
| CDMO(元) | 52,857,099.15 | 261,996,104.98 |
| 贸易类(元) | 5,249,637.76 | 5,180,432.20 |
| 原料药及中间体(元) | 221,770,058.42 | 199,996,153.82 |
| 制剂类(元) | 94,992,065.40 | 113,028,744.98 |
| 毛利率(%) | ||
| CDMO(%) | 26.36 | 51.97 |
| 贸易类(%) | 13.06 | 16.20 |
| 原料药及中间体(%) | 29.69 | 29.37 |
| 制剂类(%) | 43.00 | 50.78 |
| 收入构成(%) | ||
| CDMO(%) | 16.59 | 35.02 |
| 贸易类(%) | 3.32 | 2.22 |
| 原料药及中间体(%) | 61.81 | 47.30 |
| 制剂类(%) | 18.28 | 15.46 |
| 毛利构成(%) | ||
| CDMO(%) | 14.10 | 45.16 |
| 贸易类(%) | 1.40 | 0.89 |
| 原料药及中间体(%) | 59.16 | 34.47 |
| 制剂类(%) | 25.34 | 19.48 |